Clinical Pharmacogenomics of Thiopurine S-methyltransferase

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|1|1|119-128

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.1, Iss.1, 2006-01, pp. : 119-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomics

By McLeod Howard L   Siva Chokkalingam  

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 89-98

Future Medicine

Access to resources Recommend Favorite

Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms

By  

Current Pharmacogenomics, Vol. 5, Iss. 2, 2007-06 ,pp. : 103-115

Bentham Science Publishers

Access to resources Recommend Favorite

Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond

By Karas-Kuzelicki Natasa   Mlinaric-Rascan Irena  

Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. : 1309-1322

Future Medicine

Access to resources Recommend Favorite

Clinical Utility of Thiopurine S -Methyltransferase Genotyping

By Corominas H.  

American Journal of PharmacoGenomics, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population study

By Cooper Sheldon C   Ford Loretta T   Berg Jonathan D   Lewis Matthew JV  

Pharmacogenomics, Vol. 9, Iss. 3, 2008-03 ,pp. : 303-309

Future Medicine

Access to resources Recommend Favorite